When combined with an existing test, new test detects nearly 70 percent of pancreatic cancers with a less than 5 percent false-positive rate
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.